Y-Intercept (HK)’s OnKure Therapeutics OKUR Stock Holding History
Bought
Maintained
Sold
Other funds holding OKUR
Y-Intercept (HK)'s OKUR Position: Q2 2026 in Review
Y-Intercept (HK) opened a new position in OnKure Therapeutics (OKUR) in Q2 2026: 11,288 shares worth $51.5K. The stake represents ﹤0.01% of the portfolio and ranks #1624 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in OKUR as recently as Q2 2024.
Y-Intercept (HK) first reported a position in OKUR in Q2 2024 and has held it in 2 quarters since. The position peaked at $84.1K in Q2 2024. 3 funds tracked by Wall St. Rank hold OKUR as of Q2 2026.
- Y-Intercept (HK) held 11,288 shares of OnKure Therapeutics worth $51.5K as of Q2 2026.
- OnKure Therapeutics was a new Y-Intercept (HK) position in Q2 2026.
- OnKure Therapeutics made up ﹤0.01% of Y-Intercept (HK)'s portfolio in Q2 2026, its #1624 holding.
- Y-Intercept (HK) first reported a position in OnKure Therapeutics in Q2 2024 and has held it in 2 quarters since.
- Y-Intercept (HK)'s OnKure Therapeutics position peaked at $84.1K in Q2 2024.
- 3 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q2 2026.
Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.